Clinical data
Trade names Generic (formerly Vantin)
AHFS/Drugs.com Monograph
MedlinePlus a698024
  • AU: B1
  • US: B (No risk in non-human studies)
Routes of
ATC code J01DD13 (WHO)
Legal status
Legal status
Pharmacokinetic data
Bioavailability 50%
Protein binding 21% to 29%
Metabolism Negligible. Cefpodoxime proxetil is metabolized to cefpodoxime by the liver
Biological half-life 2 hours
Excretion Renal, unchanged
CAS Number 80210-62-4 N
PubChem (CID) 6335986
DrugBank DB01416 N
ChemSpider 4891496 YesY
KEGG D07650 YesY
Chemical and physical data
Formula C15H17N5O6S2
Molar mass 427.458 g/mol
3D model (Jmol) Interactive image
 NYesY (what is this?)  (verify)

Cefpodoxime is an oral, third-generation cephalosporin antibiotic. It is active against most Gram-positive and Gram-negative organisms. Notable exceptions include Pseudomonas aeruginosa, Enterococcus, and Bacteroides fragilis. Currently, it is only marketed as generic preparations in the USA, according to the FDA Orange Book. It is commonly used to treat acute otitis media, pharyngitis, sinusitis, and gonorrhea. It also finds use as oral continuation therapy when intravenous cephalosporins (such as ceftriaxone) are no longer necessary for continued treatment.

Zoetis markets cefpodoxime proxetil under the trade name Simplicef for veterinary use. The dose range in dogs is 510 mg/kg body weight, administered orally, once a day.

Finecure, India markets the products under trade name Cefpo.[1]

Cefpodoxime inhibits cell wall synthesis by inhibiting the final transpeptidation step of peptidoglycan synthesis in cell walls. It has well established pharmacokinetic profile with absorption of 50%. It is indicated in community acquired pneumonia, uncomplicated skin and skin structure infections, and uncomplicated urinary tract infections.

Structural formula of cefpodoxime proxetil

Spectrum of bacterial susceptibility and resistance

Cefpodoxime has been used to fight pathogenic bacteria responsible for causing gonorrhoea, tonsillitis, pneumonia, and bronchitis. Representative pathogenic genera include Streptococcus, Haemophilus, and Neisseria. The following represents MIC susceptibility data for a few medically significant microorganisms.


Brand Name

Brand Name: Toraxim (Delta Pharma Ltd. Bangladesh), Trucef (by Renata Limited, Bangladesh).

Marketed Also As : Orelox By SanoFi-Aventis Pharma[3] MAPDOX-CV Cefpodoxime and Clavulanic acid combination

MONOTAX O (Cefpodoxime)/ MONOTAX CV (Cefpodoxime and Clavulanic acid combination)- ZYDUS BIOCHEM


  1. "Anti Biotics and Anti Bacterial". Finecurepharmaceuticalsltd. Retrieved 2012-03-27.
  2. http://www.toku-e.com/Assets/MIC/Cefpodoxime%20Free%20acid.pdf
  3. "Orelox - Drugs.com". www.drugs.com. Retrieved 2015-11-28.
This article is issued from Wikipedia - version of the 9/29/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.